Author: Zoorob, Roger J.
Source: Family Medicine and Community Health, Volume 5, Number 1, 1 May 2017, pp. 1-2(2)
I am pleased to present this special issue of Family Medicine and Community Health, entitled “The Global Burden of Preventable Cancer Mortality.” This issue was completed in collaboration with the Baylor College of Medicine (BCM) Department of Family and Community Medicine in Houston, Texas, USA. The mission of the department is to enhance population health and advance the primary care discipline through rigorous and evidence-based prevention and research. We focus our research efforts on a broad range of research areas including, but not limited to, cancer control, nutrition and health, medical education, and health disparities.
Herein we explore key issues in global cancer mortality and prevention. According to estimates from the World Health Organization’s International Agency for Research on Cancer (IARC), of 14 million new cancer cases in 2012, 8 million occurred in low-middle income countries (which contain 82% of the world’s population). Cancer deaths totaled 8.2 million (with 70% in low- and middle-income countries), and estimates show there were 32.6 million people living with cancer (within five years of diagnosis) worldwide. By 2030, the global burden is expected to grow to 21.7 million new cancer cases and 13 million cancer deaths. This is due in part to the growth and aging of populations, but there are many factors and questions to investigate.